RxDoctor Payments DataLook up a doctor →

Gary Ferguson

Pulmonary Disease · Livonia, MINPI 1922016385

Payments from drug & device makers

$1,535,170in general payments, 2019–2025

Across 692 payments — averaging $2218.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$524K
  • Teva Pharmaceuticals USA, Inc.$319K
  • AstraZeneca$158K
  • Boehringer Ingelheim$103K
  • Novartis$103K
  • Astrazeneca AB$86K
  • plus $241K from 10 others
$9,816in research payments, 2019–2025

Across 8 payments — averaging $1227.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Teva Pharmaceuticals USA, Inc.$8K
  • Galderma Laboratories, L.p.$1K

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,535,170 in reported general payments places this provider in the 95th percentile of 463 pulmonary disease providers in Michigan.

See all pulmonary disease providers in Michigan

Other pulmonary disease in Livonia

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →